Spire Healthcare Group Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Spire Healthcare Group wird ein jährliches Gewinn- und Umsatzwachstum von 26.9% bzw. 6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 26.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11% betragen.

Wichtige Informationen

26.9%

Wachstumsrate der Gewinne

26.9%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	23.3%
Wachstumsrate der Einnahmen	6.0%
Zukünftige Eigenkapitalrendite	11.0%
Analystenabdeckung	Good
Zuletzt aktualisiert	19 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Spire Healthcare Group plc (LON:SPI) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Mar 07

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at Spire Healthcare Group plc (LON:SPI)

May 03

Investors Still Waiting For A Pull Back In Spire Healthcare Group plc (LON:SPI)

Jan 27

Is Now An Opportune Moment To Examine Spire Healthcare Group plc (LON:SPI)?

Oct 27

Here's Why We Think Spire Healthcare Group (LON:SPI) Is Well Worth Watching

Sep 16

Returns At Spire Healthcare Group (LON:SPI) Appear To Be Weighed Down

Jul 14

We Discuss Why Spire Healthcare Group plc's (LON:SPI) CEO Compensation May Be Closely Reviewed

May 07

Spire Healthcare Group plc (LON:SPI) Shares Could Be 30% Below Their Intrinsic Value Estimate

Apr 15

Spire Healthcare Group plc (LON:SPI) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Mar 07

Are Insiders Buying Spire Healthcare Group plc (LON:SPI) Stock?

Feb 26

Should You Think About Buying Spire Healthcare Group plc (LON:SPI) Now?

Feb 05

Spire Healthcare Group plc (LON:SPI) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jan 15

Does Spire Healthcare Group's (LON:SPI) CEO Salary Compare Well With The Performance Of The Company?

Dec 25

Here's What To Make Of Spire Healthcare Group's (LON:SPI) Returns On Capital

Dec 08

How Much Are Spire Healthcare Group plc (LON:SPI) Insiders Spending On Buying Shares?

Nov 17

Gewinn- und Umsatzwachstumsprognosen

LSE:SPI - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (GBP Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,707	81	164	305	7
12/31/2025	1,619	61	141	277	7
12/31/2024	1,526	40	120	248	7
6/30/2024	1,445	28	124	231	N/A
3/31/2024	1,402	28	128	223	N/A
12/31/2023	1,359	27	131	216	N/A
9/30/2023	1,318	24	122	201	N/A
6/30/2023	1,277	22	112	187	N/A
3/31/2023	1,238	15	103	184	N/A
12/31/2022	1,199	9	94	182	N/A
9/30/2022	1,172	8	101	186	N/A
6/30/2022	1,146	7	108	190	N/A
3/31/2022	1,126	-1	111	187	N/A
12/31/2021	1,106	-10	115	184	N/A
9/30/2021	1,091	-14	117	177	N/A
6/30/2021	1,076	-18	120	170	N/A
3/31/2021	998	-126	116	165	N/A
12/31/2020	920	-234	113	160	N/A
9/30/2020	906	-233	118	175	N/A
6/30/2020	891	-233	123	190	N/A
3/31/2020	936	-113	132	196	N/A
12/31/2019	981	7	141	202	N/A
9/30/2019	964	6	128	190	N/A
6/30/2019	947	5	116	177	N/A
3/31/2019	939	3	112	180	N/A
12/31/2018	931	0	109	183	N/A
9/30/2018	929	5	78	162	N/A
6/30/2018	926	10	47	141	N/A
3/31/2018	929	13	N/A	132	N/A
12/31/2017	932	17	N/A	124	N/A
9/30/2017	935	22	N/A	144	N/A
6/30/2017	938	27	N/A	164	N/A
3/31/2017	932	40	N/A	171	N/A
12/31/2016	926	54	N/A	177	N/A
9/30/2016	915	59	N/A	177	N/A
6/30/2016	905	65	N/A	177	N/A
3/31/2016	895	62	N/A	166	N/A
12/31/2015	885	60	N/A	155	N/A
9/30/2015	887	52	N/A	132	N/A
6/30/2015	889	45	N/A	109	N/A
3/31/2015	871	14	N/A	106	N/A
12/31/2014	856	6	N/A	113	N/A
9/30/2014	830	-24	N/A	127	N/A
6/30/2014	804	-54	N/A	142	N/A
3/31/2014	784	-54	N/A	131	N/A
12/31/2013	765	102	N/A	100	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SPIDas prognostizierte Gewinnwachstum (26.9% pro Jahr) liegt über der Sparquote (2.1%).

Ertrag vs. Markt: SPIDie Erträge des Unternehmens (26.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (14.6% pro Jahr).

Hohe Wachstumserträge: SPIEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: SPIDie Einnahmen des Unternehmens (6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (3.5% pro Jahr).

Hohe Wachstumseinnahmen: SPIDie Einnahmen des Unternehmens (6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SPIDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11%).

Spire Healthcare Group Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 14%

Spire Healthcare Group plc Provides Earnings Guidance for the Year 2022

Price target increased to UK£2.00

Price target increased to UK£1.71

Spire Healthcare Group plc (LON:SPI) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Price target raised to UK£1.50

Recent updates

Spire Healthcare Group plc (LSE:SPI) commences an Equity Buyback Plan for 40,413,223 shares, representing 10% of its issued share capital, under the authorization approved on May 9, 2024.

Returns At Spire Healthcare Group (LON:SPI) Are On The Way Up

First half 2024 earnings: EPS and revenues miss analyst expectations

Spire Healthcare Group plc Announces the Passing of Martin Angle, Deputy Chairman and Independent Non-Executive Director

Returns Are Gaining Momentum At Spire Healthcare Group (LON:SPI)

Spire Healthcare Group plc's (LON:SPI) P/E Still Appears To Be Reasonable

Upcoming dividend of UK£0.021 per share

Spire Healthcare Group plc to Report First Half, 2024 Results on Sep 12, 2024

Increases to CEO Compensation Might Be Put On Hold For Now at Spire Healthcare Group plc (LON:SPI)

Full year 2023 earnings: EPS exceeds analyst expectations

Dividend increased to UK£0.021

New major risk - Financial position

Full year 2023 earnings: EPS exceeds analyst expectations

Spire Healthcare Group plc, Annual General Meeting, May 09, 2024

Spire Healthcare Group Plc Announces Step Down of Jitesh Sodha from the Board

Spire Healthcare Group plc to Report Fiscal Year 2023 Results on Feb 29, 2024

Investors Still Waiting For A Pull Back In Spire Healthcare Group plc (LON:SPI)

Is Now An Opportune Moment To Examine Spire Healthcare Group plc (LON:SPI)?

Spire Healthcare Group plc (LSE:SPI) acquired Vita Health Group Limited from ArchiMed SAS and others for £74 million.

Consensus EPS estimates fall by 14%

First half 2023 earnings released: EPS: UK£0.031 (vs UK£0.001 loss in 1H 2022)

Here's Why We Think Spire Healthcare Group (LON:SPI) Is Well Worth Watching

Returns At Spire Healthcare Group (LON:SPI) Appear To Be Weighed Down

High number of new directors

Spire Healthcare Group plc to Report First Half, 2023 Results on Sep 14, 2023

Spire Healthcare Group plc to Report Fiscal Year 2022 Results on Feb 02, 2023

Spire Healthcare Group plc (LSE:SPI) acquired The Doctors Clinic Group Ltd from Oakfield Capital Partners LLP for £12 million.

Spire Healthcare Group plc, Annual General Meeting, May 11, 2023

Spire Healthcare Group plc to Report First Half, 2022 Results on Sep 08, 2022

Spire Healthcare Group plc, Annual General Meeting, May 11, 2022

Spire Healthcare Group plc Provides Earnings Guidance for the Year 2022

Spire Healthcare Group plc Announces Management Update

Spire Healthcare Group plc (LSE:SPI) agreed to acquire 87% stake in Operating Assets Of The Claremont Private Hospital from Aspen Healthcare Limited for £15.7 million.

Ramsay Health Care (UK) Limited cancelled the acquisition of Spire Healthcare Group plc (LSE:SPI) from Mediclinic Jersey Limited, Toscafund Asset Management LLP, Fidelity International Ltd and others.

Spire Shares Cancels from Trading on the Main Market for Listed Securities of the London Stock Exchange

Spire Shares May Cancel from Trading on the Main Market for Listed Securities of the London Stock Exchange

Price target increased to UK£2.00

Non Executive Chairman Garry Watts has left the company

We Discuss Why Spire Healthcare Group plc's (LON:SPI) CEO Compensation May Be Closely Reviewed

Price target increased to UK£1.71

Spire Healthcare Group plc (LON:SPI) Shares Could Be 30% Below Their Intrinsic Value Estimate

Full year 2020 earnings released: UK£0.58 loss per share (vs UK£0.018 profit in FY 2019)

Spire Healthcare Group plc (LON:SPI) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Sir Ian Cheshire to Join the Board of Spire Healthcare Group plc as Chairman

Full year 2020 earnings released: UK£0.58 loss per share (vs UK£0.018 profit in FY 2019)

Revenue beats expectations, earnings disappoint

Spire Healthcare Group plc Announces Executive Changes, Effective on March 4, 2021

Spire Healthcare Group plc, Annual General Meeting, May 13, 2021

Are Insiders Buying Spire Healthcare Group plc (LON:SPI) Stock?

Should You Think About Buying Spire Healthcare Group plc (LON:SPI) Now?

New 90-day high: UK£1.64

Spire Healthcare Group plc(LSE:SPI) dropped from FTSE 250 Index

Spire Healthcare Group plc (LON:SPI) Shares Could Be 37% Below Their Intrinsic Value Estimate

Price target raised to UK£1.50

New 90-day high: UK£1.60

Price target raised to UK£1.47

Does Spire Healthcare Group's (LON:SPI) CEO Salary Compare Well With The Performance Of The Company?

Spire Healthcare Group plc Provides Update on the Contract with NHS England

New 90-day high: UK£1.45

Analysts lower EPS estimates to -UK£0.53

Price target raised to UK£1.36

Here's What To Make Of Spire Healthcare Group's (LON:SPI) Returns On Capital

New 90-day high: UK£1.39

How Much Are Spire Healthcare Group plc (LON:SPI) Insiders Spending On Buying Shares?

New 90-day high: UK£1.27

Analysts update estimates

Analysts update estimates

New 90-day high: UK£1.09

Analysts update estimates